Study Details
Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis
Clinicaltrials.gov ID
Astellas Study ID
CDP870-275-11-001
EudraCT ID
N/A
Condition
Rheumatoid Arthritis
Phase
Phase 3
Age
20 years - 64 years
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Oct 2011 - Oct 2014
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
319
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of CDP870 in Patients with Early-stage Rheumatoid Arthritis Who Are Naïve to Methotrexate and Have Poor Prognostic Factors
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis? Contact us by filling our your information to the right and we’ll respond to you.